Market Research Logo

Guatemala Pharmaceuticals and Healthcare Report Q2 2016

Guatemala Pharmaceuticals and Healthcare Report Q2 2016

BMI View: The commercial incentives for foreign drugmakers to further expand in Guatemala'spharmaceutical market are limited by the country's low per capita pharmaceutical spending and subduedmarket growth. However, in spite of this, the country will continue to attract investment as a regionalpharmaceutical production hub. Since the end of the 36-year civil war in 1996, Guatemala's politicalstability has been progressing and tax incentives are available to encourage foreign investment. The keyrisks to our projection are high levels of bureaucracy, corruption, the complex judicial system and lowsecurity due to non-political violence.Headline Expenditure ProjectionsPharmaceuticals: GTQ6.6bn (USD866mn) in 2015 to GTQ7.1bn (USD917mn) in 2015; +7.1% in localcurrency terms and +5.9% in US dollar terms. Forecast has been reduced from Q116.Healthcare: GTQ30.7bn (USD4.0bn) in 2015 to GTQ32.6bn (USD4.2bn) in 2016; +6.2% in local currencyterms, +5.0% in US dollar terms. Forecast has been reduced from Q116.


BMI Industry View
Table: Headline Pharmaceuticals & Healthcare Forecasts (Guatemala 2014-2020)
SWOT
Industry Forecast
Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Guatemala 2012-2020)
Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Guatemala 2012-2020)
Industry Risk/Reward Index
Americas Risk/Reward Index
Industry Risk/Reward Index
Rewards
Risks
Regulatory Review
Market Overview
Healthcare Sector
Clinical Trials
Epidemiology
Table: Medicines Expenditure On Key Mental Health Disorders In Guatemala (2011)
Competitive Landscape
Company Profile
Donovan Werke
Demographic Forecast
Demographic Outlook
Table: Population Headline Indicators (Guatemala 1990-2025)
Table: Key Population Ratios (Guatemala 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Guatemala 1990-2025)
Table: Population By Age Group (Guatemala 1990-2025)
Table: Population By Age Group % (Guatemala 1990-2025)
Glossary
Methodology
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report